Physiologic and pathologic experimental models for studying cholangiocytes.
10.3350/kjhep.2008.14.2.139
- Author:
Seung Ok LEE
1
Author Information
1. Division of Gatroenterology and Hepatology, Department of Internal Medicine, Chonbuk National University Hospital and Medical School, Jeonju, Korea. solee@chonbuk.ac.kr
- Publication Type:Review ; English Abstract
- Keywords:
Cholangiocyte;
Experimental models
- MeSH:
Animals;
Bile Duct Diseases/etiology;
Bile Ducts/*cytology/physiology/*physiopathology;
Disease Models, Animal;
Epithelial Cells/metabolism/physiology;
Humans;
Imaging, Three-Dimensional;
Mice;
Models, Animal
- From:The Korean Journal of Hepatology
2008;14(2):139-149
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Cholangiocytes (epithelial cells lining the intra- and extrahepatic bile ducts) and hepatocytes are two major components of liver epithelia. Although cholangiocytes are less numerous than hepatocytes, they are involved in both bile secretion and diverse cellular processes such as cell-cycle phenomena, cell signaling, and interactions with other cells, matrix components, foreign organisms, and xenobiotics. Cholangiocytes are also targets in several human diseases including cholangiocarcinoma, primary sclerosing cholangitis, autoimmune cholangitis, and vanishing bile-duct syndrome. The rapid advances in experimental biology technologies are greatly expanding interest in and knowledge of the physiology and pathophysiology of cholangiocytes. This review focuses on the progress of in vivo and in vitro experimental models in elucidating the physiologic functions of cholangiocytes and the pathophysiology of various cholangiopathies. The following aspects are reviewed: isolation of cholangiocytes from the liver and their heterogeneity, various culture systems, establishment of cholangiocyte cell lines, isolation and usage of intrahepatic bile-duct units, three-dimensional modeling of the bile duct, experimental models for inducing cholangiocyte proliferation, and various cholangiopathies such as cholangiocarcinoma, primary sclerosing cholangitis, and autoimmune cholangitis.
